Brain natriuretic peptide response is heterogeneous during β-blocker therapy for congestive heart failure

This publication has 22 references indexed in Scilit:

• Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
  New England Journal of Medicine, 2002
• Comparative Left Ventricular Functional and Neurohumoral Effects of Chronic Treatment With Carvedilol Versus Metoprolol in Patients With Dilated Cardiomyopathy
  Japanese Circulation Journal, 2001
• Effectiveness of carvedilol alone versus carvedilol + pimobendan for severe congestive heart failure
  The American Journal of Cardiology, 2000
• Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
  The Lancet, 2000
• Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
  The Lancet, 1997
• Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart Failure
  Circulation, 1997
• Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
  Circulation, 1994
• Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.
  Circulation, 1993
• Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.
  Circulation, 1993
• Effects of long-term .BETA.-blockade (metoprolol) therapy in patients with dilated cardiomyopathy.
  Japanese Circulation Journal, 1991